Lakefront Biotherapeutics | GLPG - Ebitda





Ebitda Veränderung Datum
argenx SE USD 427M 22.88M 2026-03
AstraZeneca USD 5.16B 510M 2026-06
Biogen USD 649.7M 76.5M 2026-03
Genmab DKK 401M 186M 2026-06
Gilead Sciences USD 3.51B 489M 2026-03
GlaxoSmithKline GBP 3.51B 734M 2026-06
GRIFOLS EUR 473M 120M 2026-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Incyte USD 778.57M 410.6M 2026-06
Merck EUR 1.6B 69M 2026-06
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 6.48B 1.19B 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
UCB EUR 1.6B 570M 2025-12
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06